On day 22 of treatment, incidences of intracranial CVS, delayed cerebral ischemia, secondary cerebral infarction, rehemorrhage, neurologic deficits, and death were assessed
[ncbi.nlm.nih.gov]
There was no neurologic deficit.
[ncbi.nlm.nih.gov]
deficits from arterial spasm.
[ncbi.nlm.nih.gov]